United States · FDA National Drug Code directory
Rivastigmine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-065_0044f1d7-613c-4611-8481-13032c8cb390
- Product NDC
- 62332-065
- Form
- CAPSULE
- Composition / generic term
- Rivastigmine Tartrate
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220612
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE TARTRATE — 4.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62332-065-10) / 10 CAPSULE in 1 BLISTER PACK · 62332-065-10
- 30 CAPSULE in 1 BOTTLE (62332-065-30) · 62332-065-30
- 60 CAPSULE in 1 BOTTLE (62332-065-60) · 62332-065-60
- 500 CAPSULE in 1 BOTTLE (62332-065-71) · 62332-065-71
- 1000 CAPSULE in 1 BOTTLE (62332-065-91) · 62332-065-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →